Contact this trialFirst, we need to learn more about you.
Proteinase Inhibitor
Alpha-1 MP for Emphysema Due to AATD
Recruiting1 awardPhase 3
Wilmington, North Carolina
This trial is testing whether a drug called Alpha-1 MP is effective and safe for treating people with a disease called 3-year CT of the lungs. The study will last for 156 weeks and will involve two different dose regimens of the drug.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.